Identification of a candidate genetic variant for the high prevalence of type II diabetes in Polynesians

The prevalence of non-insulin-dependent diabetes mellitus (type II diabetes) in Polynesia is among the highest recorded worldwide and is substantially higher than in neighboring human populations. Such large differences in the frequency of a phenotype between populations may be explained by large allele frequency differences between populations in genes associated with the phenotype. To identify genes that may explain the high between-population variation in type II diabetes prevalence in the Pacific, we determined the frequency of 10 type II diabetes-associated alleles in 23 Polynesians, 23 highland New Guineans and 19 Han Chinese, calculated population-pairwise Fst values for each allele and compared these values to the distribution of Fst values from ∼100 000 SNPs from the same populations. The susceptibility allele in the PPARGC1A gene is at a frequency of 0.717 in Polynesians, 0.368 in Chinese but is absent in the New Guineans. The striking frequency difference between Polynesians and New Guineans is highly unusual (Fst=0.703, P=0.007) and we therefore suggest that this allele may play a role in the large difference in type II diabetes prevalence between Polynesians and neighboring populations.

[1]  P. Bennett,et al.  Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. , 1978, American journal of epidemiology.

[2]  P. Baker,et al.  Bergmann's rule and the thrifty genotype. , 1997, American journal of physical anthropology.

[3]  P. Underhill,et al.  Melanesian origin of Polynesian Y chromosomes , 2000, Current Biology.

[4]  W. Jia,et al.  Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities , 2007, Diabetologia.

[5]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[6]  P. Couzigou,et al.  The prevalence of diabetes mellitus and impaired glucose tolerance in melanesians and part-polynesians in Rural New Caledonia and ouvea (Loyalty Islands) , 1982, Diabetologia.

[7]  M. Shriver,et al.  Interrogating a high-density SNP map for signatures of natural selection. , 2002, Genome research.

[8]  Marc Montminy,et al.  CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 , 2001, Nature.

[9]  David Glenn Smith,et al.  Examining the Farming/Language Dispersal Hypothesis. , 2005 .

[10]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[11]  I. Prior.  The Price Of Civilization , 1971 .

[12]  M. Stoneking,et al.  Geographic variation in human mitochondrial DNA from Papua New Guinea. , 1990, Genetics.

[13]  P. Underhill,et al.  Reduced Y-chromosome, but not mitochondrial DNA, diversity in human populations from West New Guinea. , 2003, American journal of human genetics.

[14]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[15]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[16]  P. Zimmet,et al.  Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". , 1991, American journal of epidemiology.

[17]  S. P. Fodor,et al.  Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays , 2004, Nature Methods.

[18]  M. Ehm,et al.  An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. , 1998, The Journal of clinical investigation.

[19]  N F Box,et al.  Human pigmentation genes: identification, structure and consequences of polymorphic variation. , 2001, Gene.

[20]  Y. Pak,et al.  Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) on mitochondrial transcription factor A (Tfam) promoter , 2006 .

[21]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[22]  O. Pedersen,et al.  A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. , 2003, Diabetes.

[23]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[24]  Shu Ye,et al.  PIRA PCR designer for restriction analysis of single nucleotide polymorphisms , 2001, Bioinform..

[25]  Y. Pak,et al.  Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. , 2006, Biochemical and biophysical research communications.

[26]  B. Weir,et al.  ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.

[27]  S. Levinson,et al.  Structural Phylogenetics and the Reconstruction of Ancient Language History , 2005, Science.

[28]  C. Bustamante,et al.  Selective sweep mapping of genes with large phenotypic effects. , 2005, Genome research.

[29]  H. King,et al.  Glucose tolerance in Papua New Guinea: ethnic differences, association with environmental and behavioural factors and the possible emergence of glucose intolerance in a highland community , 1989, The Medical journal of Australia.

[30]  J Tuomilehto,et al.  Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[31]  P. Houghton.  The adaptive significance of Polynesian body form. , 1990, Annals of human biology.

[32]  J. Liu,et al.  [Prevalence of diabetes and its risk factors in China 1994. National Diabetes Prevention and Control Cooperative Group]. , 1997, Zhonghua nei ke za zhi.

[33]  M. Beaumont.  Adaptation and speciation: what can F(st) tell us? , 2005, Trends in ecology & evolution.

[34]  Guillaume Adelmant,et al.  Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 , 2001, Nature.

[35]  H. King,et al.  The epidemiology and natural history of NIDDM--lessons from the South Pacific. , 1990, Diabetes/metabolism reviews.

[36]  P. Zimmet.  Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted? , 2000, Journal of internal medicine.

[37]  J. Rees.  Genetics of hair and skin color. , 2003, Annual review of genetics.

[38]  H. Kronenberg,et al.  Globin genes in Polynesians have many rearrangements including a recently described gamma gamma gamma gamma/. , 1986, American journal of human genetics.

[39]  K. Ge,et al.  Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China , 2007, International Journal of Obesity.

[40]  K. Makova,et al.  Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans , 2005, Peptides.

[41]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[42]  R. Beizer.  Prevalence of abnormal glucose tolerance in six Solomon Islands populations. , 1990, American journal of physical anthropology.

[43]  L. Groop,et al.  Candidate Genes for Type 2 Diabetes , 2004, Reviews in Endocrine and Metabolic Disorders.

[44]  P. Zimmet,et al.  Extraordinary prevalence of non‐insulin‐dependent diabetes mellitus and bimodal plasma glucose distribution in the Wanigela people of Papua New Guinea , 1994, The Medical journal of Australia.

[45]  J. Gulcher,et al.  Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution , 2007, Nature Genetics.

[46]  Zhiqiang Wang,et al.  Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. , 2006, Diabetes research and clinical practice.

[47]  P. Underhill,et al.  Melanesian and Asian origins of Polynesians: mtDNA and Y chromosome gradients across the Pacific. , 2006, Molecular biology and evolution.

[48]  H. King,et al.  Glucose tolerance and ancestral genetic admixture in six semitraditional pacific populations , 1984, Genetic epidemiology.

[49]  Kerin O’Dea,et al.  Westernisation, insulin resistance and diabetes in Australian Aborigines , 1991, The Medical journal of Australia.

[50]  P. Zimmet,et al.  The high prevalence of diabetes mellitus on a Central Pacific island , 1977, Diabetologia.

[51]  D. Balding,et al.  Identifying adaptive genetic divergence among populations from genome scans , 2004, Molecular ecology.

[52]  H. King,et al.  Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. , 1983, American journal of epidemiology.

[53]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[54]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 1962. , 1999, Bulletin of the World Health Organization.

[55]  M. Stoneking,et al.  Identifying genes underlying skin pigmentation differences among human populations , 2006, Human Genetics.

[56]  R. Thornton,et al.  Changing patterns of hypertension, diabetes, obesity and diet among Melanesians and Micronesians in the Solomon Islands , 1987, The Medical journal of Australia.